Preparing for the Biggest Oncology Event of the Year

Preparing for the Biggest Oncology Event of the Year

Jonathan S. Berek, MD, MMedSc, FASCO

Apr 24, 2015

Dear Colleagues:

For many of us, the ASCO Annual Meeting is simply known as “ASCO.” It’s when we can count on learning about new scientific advances—some that will be truly practice changing. It’s where we come together to absorb and debate the many changes in our field, and most importantly perhaps, it’s where we can form new collaborative partnerships and catch up with old friends.

Our cover story provides the highlights of this year’s Scientific Program, including a sneak peek of the Plenary Session and the new Pathways Clinical Science Symposia, which will address immunotherapy, targeted therapies, and multi-gene assays.

This year’s theme—“Illumination and Innovation: Transforming Data into Learning”—promises to come to life in many of the sessions and help us answer the always relevant question: how do we bring the value of new discoveries to our patients?

ASCO is always looking for ways to simplify the Meeting experience for its 30,000+ attendees from around the world. In this issue, we offer you at-a-glance information on how to access Annual Meeting-related products and resources via the Attendee Resource Center (am.asco.org/arc) and the iPlanner scheduling tool. And if you can’t attend this year’s Meeting but still want to follow along in real time, you can do so via Twitter; see the list for Featured Voices on Twitter and suggestions for popular oncology-related hashtags.

Also in this issue you will find a summary of the Society’s recently released The State of Cancer Care in America: 2015 report. This important publication captures the attention of Congress and the media in its documentation of the stresses facing oncology practices and how such stresses affect cancer care.

I am pleased to say that we have more scientific content than ever in this issue with a new Current Controversies in Oncology column—this one on the timing of therapies for patients with resectable hepatic colorectal metastases—as well as highlights from the GI and GU Cancers Symposia, with follow-up GU-related Q&As from attendees/faculty of recent meetings.

Please visit us online at ASCO connection.org to comment on these and other articles.

As always, thank you for reading.

Disclaimer: 

The ideas and opinions expressed on the ASCO Connection Blogs do not necessarily reflect those of ASCO. None of the information posted on ASCOconnection.org is intended as medical, legal, or business advice, or advice about reimbursement for health care services. The mention of any product, service, company, therapy or physician practice on ASCOconnection.org does not constitute an endorsement of any kind by ASCO. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in, posted on, or linked to this site, or any errors or omissions.

Advertisement
Back to Top